Annual D&A
$562.00 K
+$91.00 K+19.32%
December 31, 2022
Summary
- As of February 9, 2025, BVXV annual depreciation & amortization is $562.00 thousand, with the most recent change of +$91.00 thousand (+19.32%) on December 31, 2022.
- During the last 3 years, BVXV annual D&A has risen by +$87.00 thousand (+18.32%).
Performance
BVXV Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$147.00 K
+$9000.00+6.52%
June 30, 2023
Summary
- As of February 9, 2025, BVXV quarterly depreciation & amortization is $147.00 thousand, with the most recent change of +$9000.00 (+6.52%) on June 30, 2023.
- Over the past year, BVXV quarterly D&A has increased by +$2000.00 (+1.38%).
Performance
BVXV Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$285.00 K
+$2000.00+0.71%
June 30, 2023
Summary
- As of February 9, 2025, BVXV TTM depreciation & amortization is $285.00 thousand, with the most recent change of +$2000.00 (+0.71%) on June 30, 2023.
- Over the past year, BVXV TTM D&A has increased by +$6000.00 (+2.15%).
Performance
BVXV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
BVXV Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.3% | +1.4% | +2.1% |
| 3 y3 years | +18.3% | - | - |
| 5 y5 years | +343.9% | +107.0% | - |
BVXV Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -16.2% | at high | -8.8% | at high | -53.0% |
| 5 y | 5-year | -25.8% | -16.2% | at high | -8.8% | at high | -53.0% |
| alltime | all time | -25.8% | -87.7% | at high | -132.7% | at high | -82.5% |
BiondVax Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $147.00 K(+6.5%) | $285.00 K(+0.7%) |
| Mar 2023 | - | $138.00 K(-4.8%) | $283.00 K(+1.4%) |
| Dec 2022 | $562.00 K(+19.3%) | - | - |
| Jun 2022 | - | $145.00 K(+8.2%) | $279.00 K(+108.2%) |
| Mar 2022 | - | $134.00 K(+79.4%) | $134.00 K(+30.4%) |
| Dec 2021 | $471.00 K(-37.8%) | - | - |
| Dec 2020 | $757.60 K(+59.5%) | - | - |
| Dec 2019 | $475.00 K(+588.4%) | - | - |
| Jun 2019 | - | $74.70 K(+3.5%) | $102.80 K(+3.7%) |
| Mar 2019 | - | $72.20 K(+1705.0%) | $99.10 K(+43.6%) |
| Dec 2018 | $69.00 K(-45.5%) | $4000.00(-108.3%) | $69.00 K(-17.8%) |
| Sep 2018 | - | -$48.10 K(-167.7%) | $83.90 K(-49.6%) |
| Jun 2018 | - | $71.00 K(+68.6%) | $166.50 K(+30.6%) |
| Mar 2018 | - | $42.10 K(+122.8%) | $127.50 K(+0.8%) |
| Dec 2017 | $126.60 K | $18.90 K(-45.2%) | $126.50 K(-12.6%) |
| Sep 2017 | - | $34.50 K(+7.8%) | $144.70 K(-5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $32.00 K(-22.1%) | $153.40 K(-4.9%) |
| Mar 2017 | - | $41.10 K(+10.8%) | $161.30 K(-0.1%) |
| Dec 2016 | $161.40 K(+0.3%) | $37.10 K(-14.1%) | $161.50 K(-1.5%) |
| Sep 2016 | - | $43.20 K(+8.3%) | $163.90 K(+2.9%) |
| Jun 2016 | - | $39.90 K(-3.4%) | $159.30 K(-1.8%) |
| Mar 2016 | - | $41.30 K(+4.6%) | $162.30 K(+0.9%) |
| Dec 2015 | $160.90 K(-7.5%) | $39.50 K(+2.3%) | $160.90 K(+2.7%) |
| Sep 2015 | - | $38.60 K(-10.0%) | $156.60 K(+0.1%) |
| Jun 2015 | - | $42.90 K(+7.5%) | $156.40 K(-4.5%) |
| Mar 2015 | - | $39.90 K(+13.4%) | $163.70 K(-5.8%) |
| Dec 2014 | $173.90 K(-14.6%) | $35.20 K(-8.3%) | $173.80 K(+25.4%) |
| Sep 2014 | - | $38.40 K(-23.5%) | $138.60 K(+38.3%) |
| Jun 2014 | - | $50.20 K(+0.4%) | $100.20 K(+100.4%) |
| Mar 2014 | - | $50.00 K | $50.00 K |
| Dec 2013 | $203.60 K(+4.0%) | - | - |
| Dec 2012 | $195.70 K(+24.2%) | - | - |
| Dec 2011 | $157.60 K | - | - |
FAQ
- What is BiondVax Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual D&A year-on-year change?
- What is BiondVax Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly D&A year-on-year change?
- What is BiondVax Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals TTM D&A year-on-year change?
What is BiondVax Pharmaceuticals annual depreciation & amortization?
The current annual D&A of BVXV is $562.00 K
What is the all time high annual D&A for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual depreciation & amortization is $757.60 K
What is BiondVax Pharmaceuticals annual D&A year-on-year change?
Over the past year, BVXV annual depreciation & amortization has changed by +$91.00 K (+19.32%)
What is BiondVax Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of BVXV is $147.00 K
What is the all time high quarterly D&A for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly depreciation & amortization is $147.00 K
What is BiondVax Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, BVXV quarterly depreciation & amortization has changed by +$2000.00 (+1.38%)
What is BiondVax Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of BVXV is $285.00 K
What is the all time high TTM D&A for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high TTM depreciation & amortization is $285.00 K
What is BiondVax Pharmaceuticals TTM D&A year-on-year change?
Over the past year, BVXV TTM depreciation & amortization has changed by +$6000.00 (+2.15%)